← back to search

Xavier Castells

Red de Investigación en Actividades Preventivas y Promoción de la Salud · ES
Area of research
Oncology · Cancer Research
Research interest
Research interests include Global Cancer Incidence and Screening, Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, and Colorectal Cancer Screening and Detection.
h-index
48
citations
6,943
works
341
NIH funding
primary concept
Medicine
email

Recent publications

"Unanswered questions": Acceptability of a personalised breast cancer screening strategy in lower-risk women by healthcare professionals in the context of the MyPeBS study.
2026cited by 0position: contributordoi
Effect of long-term adherence on faecal immunochemical test positivity rate, positive predictive value and detection rate in organised population-based colorectal cancer screening.
2026cited by 0position: contributordoi
Urinary incontinence in health workers as a predisposing factor for presenteeism in Chile: A mixed-methods exploratory study.
2024cited by 0position: contributordoi
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain.
2024cited by 0position: contributordoi
Correction: Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.
2024cited by 0position: contributordoi
Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.
2023cited by 9position: contributordoi
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial
BMC Cancer 2022cited by 100position: middledoi
Impact of COVID-19 on Hospital Admissions and Healthcare Quality Indicators in Non-COVID Patients: A Retrospective Study of the First COVID-19 Year in a University Hospital in Spain.
2022cited by 11position: contributordoi
Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening.
2022cited by 11position: contributordoi
Effectiveness and Cost-Effectiveness of Case Management in Advanced Heart Failure Patients Attended in Primary Care: A Systematic Review and Meta-Analysis.
2022cited by 10position: contributordoi
Exploring the Association of Cancer and Depression in Electronic Health Records: Combining Encoded Diagnosis and Mining Free-Text Clinical Notes.
2022cited by 5position: contributordoi
Impact of Detection Mode in a Large Cohort of Women Taking Part in a Breast Screening Program.
2022cited by 3position: contributordoi
Use of health services among long-term breast cancer survivors in Spain: longitudinal study based on real-world data.
2022cited by 3position: contributordoi
Exploring the Association of Cancer and Depression in Electronic Health Records: Combining Encoded Diagnosis and Mining Free-Text Clinical Notes (Preprint)
2022cited by 0position: contributordoi
Effects of Environmental Factors on Severity and Mortality of COVID-19
Frontiers in Medicine 2021cited by 55position: middledoi
Hospital-at-Home Expands Hospital Capacity During COVID-19 Pandemic.
2021cited by 41position: contributordoi
Breast density, benign breast disease, and risk of breast cancer over time.
2021cited by 23position: contributordoi
Multimorbidity clusters among long-term breast cancer survivors in Spain: Results of the SURBCAN study.
2021cited by 19position: contributordoi
Factors that Influence Treatment Delay for Patients with Breast Cancer.
2021cited by 19position: contributordoi
Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening
PLOS ONE 2021cited by 15position: contributordoi
[Informed choice in breast cancer screening: the role of education].
2021cited by 10position: contributordoi
Effect of an information leaflet on breast cancer screening participation: A cluster randomized controlled trial.
2021cited by 8position: contributordoi
Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers.
2021cited by 8position: contributordoi
Interobserver and Intertest Agreement in Telemedicine Glaucoma Screening with Optic Disk Photos and Optical Coherence Tomography.
2021cited by 7position: contributordoi
Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
2021cited by 4position: contributordoi
Impact and Management of COVID-19 Among Healthcare Workers in Two Acute Care Hospitals and Two Associated Long-term Care Centres in Barcelona, Spain.
2021cited by 3position: contributordoi
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines.
2020cited by 175position: contributordoi
Effects of Environmental Factors on Severity and Mortality of COVID-19.
2020cited by 37position: contributordoi
Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain.
2020cited by 30position: contributordoi
Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators.
2020cited by 23position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 18 papers (2019–2026)Maria Sala · Agència de Salut Pública de Catalunya12 papers (2019–2024)Juan Pablo Horcajada · Montreal Heart Institute6 papers (2019–2021)Maximino Redondo · Andalusian Centre for Nanomedicine and Biotechnology5 papers (2021–2024)Javier Louro · Karolinska Institutet5 papers (2019–2024)Anna Jansana · Red de Investigación en Actividades Preventivas y Promoción de la Salud3 papers (2020–2022)Marta Román · Red de Investigación en Actividades Preventivas y Promoción de la Salud3 papers (2021–2026)Miguel A. Prieto · Galicia Sur Biomedical Foundation3 papers (2019–2021)Amado Rivero · Centro de Investigación Biomédica en Red3 papers (2021–2024)Susana García-Gutiérrez · Clarivate PLC3 papers (2021–2024)José M. Quintana · Energy Sciences Network3 papers (2021–2024)Paolo Giorgi Rossi · Tecnologie Avanzate (Italy)2 papers (2019–2022)Rafael Marcos‐Gragera · Generalitat de Catalunya2 papers (2020–2021)Francesco Ronzano · Universitat Pompeu Fabra2 papers (2022–2022)Carme Miret · Hospital del Mar Research Institute2 papers (2023–2024)Olatz Garin · Hospital del Mar Research Institute2 papers (2023–2024)Antoni Castells · Fundació Clínic per a la Recerca Biomèdica2 papers (2019–2026)Miranda Langendam · University College London2 papers (2020–2021) · 2 papers (2020–2021)Montse Ferrer · Center for Research in Environmental Epidemiology2 papers (2023–2024)